why choose us

First received: November 21, 2022

Clinical Trial: Circulating Tumor Cells Screen for Breast Cancer

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Breast Neoplasm
Neoplastic Cells, Circulating

Study Type: Observational [Patient Registry]


Official Title: Detection of Folate Receptor-positive Circulating Tumor Cells as a Biomarker for Diagnosis

Brief Summary: A prospective study was used to collect patients considering breast cancer admitted to our general surgery department from 2019-6 to 2023-8, to identify the case group (breast cancer) and the control group (non-breast cancer), to compare the differences in CTC in peripheral blood between the two groups, and to draw conclusions after statistical analysis.

Read more